393 related articles for article (PubMed ID: 16605301)
1. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
Hadighi R; Mohebali M; Boucher P; Hajjaran H; Khamesipour A; Ouellette M
PLoS Med; 2006 May; 3(5):e162. PubMed ID: 16605301
[TBL] [Abstract][Full Text] [Related]
2. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M
Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of meglumine antimoniate against L. tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran.
Karamian M; Bojd MS; Salehabadi A; Hemmati M; Barati DA
East Mediterr Health J; 2015 Jun; 21(4):280-6. PubMed ID: 26077523
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients.
Hajjaran H; Azarian B; Mohebali M; Hadighi R; Assareh A; Vaziri B
East Mediterr Health J; 2012 Feb; 18(2):165-71. PubMed ID: 22571094
[TBL] [Abstract][Full Text] [Related]
5. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.
Nateghi-Rostami M; Tasbihi M; Darzi F
Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060
[TBL] [Abstract][Full Text] [Related]
6. The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.
Sezavar M; Sharifi I; Ghasemi Nejad Almani P; Kazemi B; Davoudi N; Salari S; Salarkia E; Khosravi A; Bamorovat M
J Clin Lab Anal; 2021 Mar; 35(3):e23670. PubMed ID: 33283321
[TBL] [Abstract][Full Text] [Related]
7. Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.
Oliaee RT; Sharifi I; Afgar A; Kareshk AT; Asadi A; Heshmatkhah A; Bamorovat M; Jafarzadeh A; Mohammadi MA; Daneshvar H
Trop Med Int Health; 2018 Jun; 23(6):622-633. PubMed ID: 29709098
[TBL] [Abstract][Full Text] [Related]
8. Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica.
Arana FE; Pérez-Victoria JM; Repetto Y; Morello A; Castanys S; Gamarro F
Biochem Pharmacol; 1998 Nov; 56(9):1201-8. PubMed ID: 9802332
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study.
Özbilgin A; Çavuş İ; Yıldırım A; Kaya T; Ertabaklar H
Turkiye Parazitol Derg; 2018 Mar; 42(1):11-19. PubMed ID: 29780014
[TBL] [Abstract][Full Text] [Related]
10. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.
Shokri A; Sharifi I; Khamesipour A; Nakhaee N; Fasihi Harandi M; Nosratabadi J; Hakimi Parizi M; Barati M
Parasitol Res; 2012 Mar; 110(3):1113-7. PubMed ID: 21847598
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.
Hajjaran H; Kazemi-Rad E; Mohebali M; Oshaghi MA; Khadem-Erfan MB; Hajaliloo E; Reisi Nafchi H; Raoofian R
Int J Dermatol; 2016 Sep; 55(9):1020-6. PubMed ID: 27336481
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Grogl M; Thomason TN; Franke ED
Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.
Oliaee RT; Sharifi I; Afgar A; Jafarzadeh A; Kareshk AT; Bamorovat M; Sharifi H; Babaei Z; Keyhani A; Keyhani A; Abedi L; Sharifi F
Microb Pathog; 2019 Jan; 126():368-378. PubMed ID: 30399441
[TBL] [Abstract][Full Text] [Related]
14. Correlation between clinical responses with the drugsusceptibility of parasites in Iranian cutaneous leishmaniasis caused by Leishmania major.
Zarean M; Maraghi SH; Hajjaran H; Mohebali M; Feiz-Haddad MH; Assarehzadegan MA
Trop Biomed; 2016 Jun; 34(2):338-345. PubMed ID: 33593014
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
[TBL] [Abstract][Full Text] [Related]
16. Comparison of
Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime.
Ezatkhah F; Sharifi I; Babaei Z; Baneshi MR; Zolala F; Kermanizadeh A; Keyhani A; Sharifi M; Dezaki ES; Aflatoonian MR; Aflatoonian B; Khatami M; Bamorovat M
J Vector Borne Dis; 2019; 56(4):351-359. PubMed ID: 33269736
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate.
Perez-Franco JE; Cruz-Barrera ML; Robayo ML; Lopez MC; Daza CD; Bedoya A; Mariño ML; Saavedra CH; Echeverry MC
PLoS Negl Trop Dis; 2016 May; 10(5):e0004739. PubMed ID: 27243811
[TBL] [Abstract][Full Text] [Related]
19. Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility.
Moreira ES; Anacleto C; Petrillo-Peixoto ML
Parasitol Res; 1998 Sep; 84(9):720-6. PubMed ID: 9766900
[TBL] [Abstract][Full Text] [Related]
20. [Determination of Antimony Resistance Mechanism of Leishmania tropica Causing Cutaneous Leishmaniasis in Turkey].
Özbilgin A; Zeyrek FY; Güray MZ; Çulha G; Akyar I; Harman M; Özbel Y; Ertabaklar H; Çavuş İ; Gündüz C
Mikrobiyol Bul; 2020 Jul; 54(3):444-462. PubMed ID: 32755520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
